查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088721

蛋白質表現市場：全球市場預測（按產品類型、表達系統、服務類型、應用和最終用戶分類）—2026-2032年

Protein Expression Market by Product Type, Expression Systems, Service Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，蛋白質表現市場規模將達到 77.2 億美元，複合年成長率為 8.45%。

主要市場統計數據
基準年 2025 43.7億美元
預計年份：2026年 47.2億美元
預測年份 2032 77.2億美元
複合年成長率 (%) 8.45%

タンパク質発現市場は、現代のバイオ医薬品イノベーションの中核に位置しており、モノクローナル抗体、ワクチン、酵素、ホルモン、細胞激素、診断薬、ならびに細胞,遺伝子治療のワークフローに向けた組換えタンパク質の生産を可能にしています。1982年に組換えヒトインスリンがFDA承認を受けた初のバイオテクノロジー医薬品となって以来、タンパク質発現技術は、実験室規模の生産から、規制に準拠した工業化されたバイオ製造へと進化してきました。

生物製藥研發管線、生物相似藥的開發、精準醫療以及哺乳動物、微生物、昆蟲、酵母、植物和無細胞表達系統的日益普及，共同推動了這項需求。對於治療性蛋白質生產商而言，策略重點不再只是生產蛋白質，而是要實現穩定的產量、正確的折疊、轉譯後修飾、純度、可擴展性以及符合監管要求的文件記錄。

蛋白質表現領域的變革性變化

蛋白質表現格局正從單一平台生產轉向特定用途的表達策略。雖然大腸桿菌仍被廣泛用於生產無需複雜糖基化的低成本蛋白質，但中國倉鼠卵巢細胞憑藉其已證實的合規性和與人類相容的翻譯後後處理，仍然是許多治療性糖蛋白的主要表達平台。

人工智慧的累積影響

人工智慧透過增強序列設計、密碼子最佳化、訊號肽選擇、溶解度預測、結構建模和可行性篩檢，進一步加速了整體蛋白質表現領域的生產力提升。公開可用的蛋白質結構預測資源加速了計算生物學的實用化。同時，機器學習也擴大被用於在實驗室規模化生產之前識別表達風險。

關鍵區域洞察

由於美國食品藥物管理局 (FDA) 嚴格的管理體制、雄厚的公共和私人生物醫學研究資金、先進的生物製造基礎設施，以及遍布美國和加拿大的眾多生物製藥創新者，北美仍然是治療性蛋白質表達領域的高價值中心。歐洲則受益於歐洲藥品管理局 (EMA) 的監管、完善的藥品生產品質管理規範 (GMP) 網路、卓越的學術水平，以及德國、法國、英國、義大利和西班牙深厚的研究實力，這些國家在疫苗、重組蛋白和分析品質系統方面擁有悠久的歷史和豐富的經驗。

關鍵的群體特定見解

在東協地區，新加坡的製造地、成熟的監管體係以及區域醫療保健需求正推動先進蛋白表達服務的應用。同時，馬來西亞、泰國、印尼、越南和菲律賓正在建構臨床、學術和製造生態系統。海灣合作理事會（GCC）國家透過在地化政策、政府投資和醫院系統現代化，吸引生物製藥、疫苗和診斷能力，進而為重組蛋白生產和技術轉移創造機會。

主要國家的概況

美國在生物製藥研發、FDA監管的生產、創業投資平台、轉化研究和先進的CDMO能力方面處於主導地位。加拿大正透過公共投資和研究夥伴關係加強其國內生物製造和疫苗基礎設施。另一方面，墨西哥則利用接近性北美供應鏈的優勢、成熟的藥品生產體係以及對生物製藥日益成長的需求。巴西是拉丁美洲最大的醫療保健市場，也是一個重要的生物製藥中心，擁有公共醫療機構和技術轉移舉措的支持。

為行業領導者提供的實用建議

產業領導者應根據​​產品的生物學特性選擇表達系統，而不是墨守成規。雖然需要複雜糖基化的蛋白質應儘早評估哺乳動物表達系統，但酵素、片段、抗原和結構簡單的重組蛋白則可能受益於微生物、酵母、昆蟲、植物或無細胞表達平台，具體取決於折疊、溶解度、表達速率和成本要求。

調查方法

本執行摘要基於二手資料研究和系統性的行業分析，參考了監管指南、科學文獻、臨床和專利趨勢、公共衛生資訊來源、生物製造能力指標以及已發布的投資和政策舉措。主要資訊來源包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、國際人用藥品註冊技術協調會 (ICH)、世界衛生組織 (WHO)、經濟合作暨發展組織 (OECD)、各國衛生組織、同行評審期刊、藥典標準和政府生物技術策略。

結論

蛋白質表現技術正從輔助研究的技術發展成為生物製藥、疫苗、精準醫療、診斷和先進療法等領域的策略性產業能力。競爭優勢將取決於表達品質、製程可重複性、分析控制、法規遵循以及從構建體設計到規模化生產的速度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 蛋白質表現市場：依產品類型分類

  • 表達向量
    • 質體
    • 病毒性的
  • 試劑
    • 緩衝溶液
    • 誘導劑
    • 培養基添加劑
  • 勝任細胞
  • 表達系統
  • 成套工具
    • 克隆試劑盒
    • 表情包

第8章 蛋白質表現市場：依表現系統分類

  • 哺乳動物
    • 暫時的
    • 穩定型
  • 細菌
    • 大腸桿菌
    • 芽孢桿菌
  • 東方
  • 昆蟲
  • 植物來源
    • 瞬間發生
    • 穩定基因改造表達
  • 無細胞法
    • 原核無細胞系統
    • 真核無細胞系統

第9章 蛋白質表現市場：依服務類型分類

  • 蛋白質純化服務
  • 蛋白質合成服務
  • 蛋白質最佳化服務

第10章 蛋白質表現市場：依應用領域分類

  • 農業
  • 診斷
  • 食物
  • 治療
    • 生物製劑
    • 基因治療
  • 疫苗

第11章 蛋白質表現市場：依最終用戶分類

  • 學術研究機構
    • 政府研究機構
    • 大學
  • 受託研究機構
    • CMO
    • CRO
  • 製藥公司
    • 生技公司
    • 大型製藥企業

第12章 蛋白質表現市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：蛋白質表現市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 蛋白質表現市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abeomics Inc
  • Agilent Technologies, Inc
  • Ajinomoto Co., Inc
  • Aragen Life Sciences Ltd
  • Bio-Rad Laboratories, Inc
  • Bio-Techne Corporation
  • Bioneer Corporation
  • Charles River Laboratories International, Inc
  • Corning Incorporated
  • Danaher Corporation
  • Eurofins Scientific SE
  • FUJIFILM Irvine Scientific, Inc
  • GenScript Biotech Corporation
  • LGC Limited
  • Lonza Group AG
  • Merck KGaA
  • New England Biolabs, Inc
  • OriGene Technologies, Inc
  • Oxford Expression Technologies Ltd
  • Promega Corporation
  • ProteoGenix Inc
  • QIAGEN NV
  • Sartorius AG
  • Sino Biological, Inc
  • Syngene International Limited
  • Synthetic Genomics Inc
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc
  • WuXi Biologics Cayman, Inc
Product Code: MRR-783E443AFB9A

The Protein Expression Market is projected to grow by USD 7.72 billion at a CAGR of 8.45% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.37 billion
Estimated Year [2026] USD 4.72 billion
Forecast Year [2032] USD 7.72 billion
CAGR (%) 8.45%

The protein expression market sits at the center of modern biopharmaceutical innovation, enabling recombinant protein production for monoclonal antibodies, vaccines, enzymes, hormones, cytokines, diagnostics, and cell and gene therapy workflows. Since recombinant human insulin became the first FDA-approved biotechnology medicine in 1982, protein expression technologies have advanced from laboratory-scale production to regulated, industrialized biomanufacturing.

Demand is reinforced by biologics pipelines, biosimilar development, precision medicine, and growing use of mammalian, microbial, insect, yeast, plant, and cell-free expression systems. For therapeutic protein manufacturers, the strategic priority is no longer simply producing protein; it is achieving consistent yield, correct folding, post-translational modification, purity, scalability, and regulatory-ready documentation.

Transformative Shifts in the Protein Expression Landscape

The protein expression landscape is shifting from single-platform production toward fit-for-purpose expression strategies. Escherichia coli remains widely used for cost-efficient proteins without complex glycosylation, while Chinese hamster ovary cells remain a leading platform for many therapeutic glycoproteins because of their proven regulatory history and human-compatible post-translational processing.

Single-use bioreactors, perfusion processing, high-throughput clone screening, chemically defined media, and improved transfection systems are reshaping upstream productivity. At the same time, quality-by-design, ICH-aligned comparability, and tighter control of host-cell proteins, host-cell DNA, endotoxins, adventitious agents, and viral safety are making process robustness a central competitive differentiator.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding productivity gains across protein expression by improving sequence design, codon optimization, signal peptide selection, solubility prediction, structural modeling, and developability screening. Publicly available protein-structure prediction resources accelerated the practical use of computational biology, while machine learning is increasingly used to identify expression liabilities before wet-lab scale-up.

In regulated manufacturing, AI is most valuable when connected to validated data infrastructure. Predictive analytics can support media optimization, bioreactor parameter control, deviation detection, and digital twins; however, GMP release decisions still require validated methods, traceable records, data integrity, and regulatory evidence. Leaders that combine AI with automation and experimental confirmation can reduce cycle time without compromising compliance.

Key Regional Insights

North America remains a high-value center for therapeutic protein expression because of FDA regulatory depth, strong public and private biomedical funding, advanced biomanufacturing infrastructure, and concentration of biologics innovators across the United States and Canada. Europe benefits from EMA oversight, established GMP networks, academic excellence, and research depth across Germany, France, the United Kingdom, Italy, and Spain, supported by long-standing capabilities in vaccines, recombinant proteins, and analytical quality systems.

Asia-Pacific is expanding through manufacturing capacity, biosimilar development, clinical research activity, and government-backed biotechnology strategies in China, India, Japan, South Korea, Singapore, and Australia. Latin America is led by Brazil and Mexico, where local biologics production, technology transfer, and public-health procurement support demand for recombinant protein expression. The Middle East is investing in pharmaceutical localization, biotechnology parks, and life-science hubs, particularly through national diversification strategies, while Africa is gaining strategic attention as vaccine and biologics manufacturing initiatives align with the African Union's objective to manufacture a larger share of the continent's vaccine needs by 2040.

Key Group Insights

Within ASEAN, Singapore's biomanufacturing base, regulatory maturity, and regional healthcare demand support adoption of advanced protein expression services, while Malaysia, Thailand, Indonesia, Vietnam, and the Philippines continue building clinical, academic, and manufacturing ecosystems. The GCC is using localization policies, sovereign investment, and hospital-system modernization to attract biologics, vaccine, and diagnostic capabilities, creating opportunities for recombinant protein production and technology transfer.

The European Union offers harmonized regulatory pathways, Horizon Europe research funding, and a mature quality culture that supports cross-border bioprocessing innovation. BRICS economies are important for biosimilar scale, public procurement, vaccine production, and cost-efficient manufacturing, especially China, India, and Brazil. G7 countries continue to lead in high-value therapeutic innovation, advanced analytics, and regulated biologics manufacturing, while NATO members increasingly view biomanufacturing resilience, medical countermeasure readiness, and secure life-science supply chains as strategic priorities.

Key Country Insights

The United States leads in biologics R&D, FDA-regulated manufacturing, venture-backed platforms, translational research, and advanced CDMO capacity. Canada is strengthening domestic biomanufacturing and vaccine infrastructure through public investment and research partnerships, while Mexico offers proximity to North American supply chains, established pharmaceutical production, and growing demand for biologics access. Brazil is Latin America's largest healthcare market and a key biologics procurement base, supported by public health institutions and technology-transfer initiatives.

In Europe, the United Kingdom combines academic translation with bioprocess innovation and clinical development depth, Germany anchors equipment, biopharma, industrial biotechnology, and quality-engineering expertise, France supports vaccine and biologics production through national life-science capacity, and Italy and Spain provide strong pharmaceutical manufacturing footprints and clinical research ecosystems. Russia retains local biologics capabilities and domestic manufacturing programs but faces geopolitical, financing, and technology-access constraints that affect international collaboration.

In Asia-Pacific, China and India are scaling biosimilars, vaccines, recombinant proteins, and contract development services through expanding talent pools and policy support; Japan emphasizes quality, specialty biologics, regenerative medicine, and precision manufacturing; South Korea is a global biologics manufacturing hub with strong government support for biopharmaceutical exports; and Australia supports clinical translation, research tools, early-stage biotechnology, and regional life-science partnerships.

Actionable Recommendations for Industry Leaders

Industry leaders should align expression-system selection with product biology rather than legacy preference. Proteins requiring complex glycosylation should be evaluated early in mammalian systems, while enzymes, fragments, antigens, and simpler recombinant proteins may benefit from microbial, yeast, insect, plant, or cell-free platforms depending on folding, solubility, speed, and cost requirements.

Executives should invest in high-throughput screening, single-use flexibility, validated analytics, AI-enabled process development, and robust data governance. Strategic sourcing of plasmids, media, resins, filters, enzymes, cell banks, and critical raw materials is essential, as supply-chain resilience has become a regulatory and operational requirement for biologics programs.

Research Methodology

This executive summary is grounded in secondary research and structured industry analysis using regulatory guidance, scientific literature, clinical and patent activity, public-health sources, biomanufacturing capacity indicators, and publicly reported investment and policy initiatives. Key references include FDA, EMA, ICH, WHO, OECD, national health agencies, peer-reviewed journals, pharmacopeial standards, and government biotechnology strategies.

Findings were triangulated across technology adoption, regulatory maturity, manufacturing footprint, therapeutic pipeline relevance, quality requirements, and regional policy direction. Qualitative insights were assessed for commercial relevance to recombinant protein production, therapeutic protein expression, biosimilars, vaccines, diagnostics, research reagents, and bioprocessing platforms, while avoiding unsupported market sizing, market share, or forecasting claims.

Conclusion

Protein expression is evolving from a research-enabling technology into a strategic industrial capability for biologics, vaccines, precision medicine, diagnostics, and advanced therapies. Competitive advantage will depend on expression quality, process reproducibility, analytical control, regulatory readiness, and speed from construct design to scalable production.

Organizations that integrate AI, automation, platform flexibility, secure supply chains, and robust quality systems will be best positioned to advance in the global protein expression market while meeting rising expectations for biologics access, safety, affordability, and manufacturing resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Protein Expression Market, by Product Type

  • 7.1. Expression Vectors
    • 7.1.1. Plasmid
    • 7.1.2. Viral
  • 7.2. Reagents
    • 7.2.1. Buffers
    • 7.2.2. Inducers
    • 7.2.3. Media Supplements
  • 7.3. Competent Cells
  • 7.4. Expression Systems
  • 7.5. Kits
    • 7.5.1. Cloning Kits
    • 7.5.2. Expression Kits

8. Protein Expression Market, by Expression Systems

  • 8.1. Mammalian
    • 8.1.1. Transient
    • 8.1.2. Stable
  • 8.2. Bacterial
    • 8.2.1. Escherichia coli based
    • 8.2.2. Bacillus based
  • 8.3. Yeast
  • 8.4. Insect
  • 8.5. Plant based
    • 8.5.1. Transient Expression
    • 8.5.2. Stable Transgenic Expression
  • 8.6. Cell Free
    • 8.6.1. Prokaryotic Cell Free System
    • 8.6.2. Eukaryotic Cell Free System

9. Protein Expression Market, by Service Type

  • 9.1. Protein Purification Services
  • 9.2. Protein Synthesis Services
  • 9.3. Protein Optimization Services

10. Protein Expression Market, by Application

  • 10.1. Agricultural
  • 10.2. Diagnostics
  • 10.3. Food
  • 10.4. Therapeutics
    • 10.4.1. Biologics
    • 10.4.2. Gene Therapy
  • 10.5. Vaccines

11. Protein Expression Market, by End User

  • 11.1. Academic & Research Institutes
    • 11.1.1. Government Labs
    • 11.1.2. Universities
  • 11.2. Contract Research Organizations
    • 11.2.1. CMOs
    • 11.2.2. CROs
  • 11.3. Pharmaceutical Companies
    • 11.3.1. Biotech Firms
    • 11.3.2. Large Pharma

12. Protein Expression Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Protein Expression Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Protein Expression Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abeomics Inc
  • 16.2. Agilent Technologies, Inc
  • 16.3. Ajinomoto Co., Inc
  • 16.4. Aragen Life Sciences Ltd
  • 16.5. Bio-Rad Laboratories, Inc
  • 16.6. Bio-Techne Corporation
  • 16.7. Bioneer Corporation
  • 16.8. Charles River Laboratories International, Inc
  • 16.9. Corning Incorporated
  • 16.10. Danaher Corporation
  • 16.11. Eurofins Scientific SE
  • 16.12. FUJIFILM Irvine Scientific, Inc
  • 16.13. GenScript Biotech Corporation
  • 16.14. LGC Limited
  • 16.15. Lonza Group AG
  • 16.16. Merck KGaA
  • 16.17. New England Biolabs, Inc
  • 16.18. OriGene Technologies, Inc
  • 16.19. Oxford Expression Technologies Ltd
  • 16.20. Promega Corporation
  • 16.21. ProteoGenix Inc
  • 16.22. QIAGEN N.V.
  • 16.23. Sartorius AG
  • 16.24. Sino Biological, Inc
  • 16.25. Syngene International Limited
  • 16.26. Synthetic Genomics Inc
  • 16.27. Takara Bio Inc
  • 16.28. Thermo Fisher Scientific Inc
  • 16.29. WuXi Biologics Cayman, Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN EXPRESSION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PROTEIN EXPRESSION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PROTEIN EXPRESSION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PROTEIN EXPRESSION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEIN EXPRESSION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PROTEIN EXPRESSION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXPRESSION VECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXPRESSION VECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PLASMID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLASMID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PLASMID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIRAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VIRAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIRAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUFFERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BUFFERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUFFERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INDUCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INDUCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INDUCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDIA SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDIA SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDIA SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPETENT CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXPRESSION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXPRESSION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CLONING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CLONING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CLONING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXPRESSION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXPRESSION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXPRESSION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAMMALIAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAMMALIAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAMMALIAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRANSIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRANSIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ESCHERICHIA COLI BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ESCHERICHIA COLI BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ESCHERICHIA COLI BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BACILLUS BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BACILLUS BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BACILLUS BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL YEAST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL YEAST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL YEAST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INSECT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INSECT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INSECT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PLANT BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLANT BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PLANT BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TRANSIENT EXPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TRANSIENT EXPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TRANSIENT EXPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STABLE TRANSGENIC EXPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STABLE TRANSGENIC EXPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STABLE TRANSGENIC EXPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL FREE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CELL FREE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL FREE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PROKARYOTIC CELL FREE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROKARYOTIC CELL FREE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PROKARYOTIC CELL FREE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EUKARYOTIC CELL FREE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EUKARYOTIC CELL FREE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EUKARYOTIC CELL FREE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PROTEIN PURIFICATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PROTEIN PURIFICATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PROTEIN PURIFICATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PROTEIN SYNTHESIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PROTEIN SYNTHESIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PROTEIN SYNTHESIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PROTEIN OPTIMIZATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PROTEIN OPTIMIZATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROTEIN OPTIMIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GOVERNMENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GOVERNMENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GOVERNMENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL UNIVERSITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL UNIVERSITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL UNIVERSITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CMOS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CMOS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CMOS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CROS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CROS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CROS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOTECH FIRMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOTECH FIRMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BIOTECH FIRMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL LARGE PHARMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL LARGE PHARMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL LARGE PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 263. GCC PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. GCC PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 314. G7 PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. G7 PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. G7 PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 317. G7 PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 318. G7 PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 319. G7 PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 320. G7 PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 321. G7 PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 322. G7 PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 323. G7 PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 324. G7 PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. G7 PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. G7 PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 327. G7 PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. G7 PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 329. G7 PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 330. G7 PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 331. NATO PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. NATO PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 334. NATO PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 335. NATO PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 336. NATO PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 337. NATO PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 338. NATO PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 339. NATO PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 340. NATO PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 341. NATO PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. NATO PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. NATO PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 344. NATO PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 345. NATO PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 346. NATO PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 347. NATO PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 348. GLOBAL PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY PLANT BASED, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 365. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 366. CANADA PROTEIN EXPRESSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 367. CANADA PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 368. CANADA PROTEIN EXPRESSION MARKET SIZE, BY EXPRESSION VECTORS, 2018-2032 (USD MILLION)
  • TABLE 369. CANADA PROTEIN EXPRESSION MARKET SIZE, BY R